Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:3/1/2019
Start Date:June 2004
End Date:December 2018

Use our guide to learn which trials are right for you!

Role of Inflammation in PML

This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy
(PML). We will focus on the role of inflammation in PML, and define prognostic markers of
disease evolution.

To determine precisely what are the host or viral factors that may predict a favorable
outcome for PML patients and the role of inflammation in preventing JCV from causing brain
disease. One of the goals of this study is to help establish non-invasive markers of PML
evolution by studying the brain metabolism in PML lesions using Magnetic Resonance Imaging
(MRI), Magnetic Spectroscopy (MRS) and other advanced imaging modalities.

Inclusion Criteria:

- PML patients of 18 years of age or older will be included in this study.

Exclusion Criteria:

1. Presence of opportunistic brain lesions other than PML. ( e.g., toxoplasmosis,
lymphoma)

2. Presence of confounding neurological disorder such as brain neoplasm etc.

In addition patients with a contraindication to MRI examination will be excluded from
study. Contraindications to the MRI examination include:

1. Medically unstable or hematological, renal, or hepatic dysfunction.

2. Cardiac pacemaker

3. Internal clips,

4. Metal implants, or external clips with 10 mm of the head.

5. Metal in the eyes.

6. Pregnant

7. Claustrophobia
We found this trial at
1
site
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials